April 8th, 2020

A full text version of this article is available.
To access article obtain online access here or login
Clinical Application of Antialdosterone-Containing Hormone Therapy for Postmenopausal Women
Authors:  Mary Jane Minkin, M.D.
  Increased awareness of the risk of cardiovascular disease (CVD) in postmenopausal women will aid clinicians in choosing the most appropriate hormone therapy (HT) for their patients. An antialdosterone-containing hormonal therapy offers postmenopausal women advantages beyond simply the relief of menopausal symptoms; drospirenone/estradiol therapy
has a theoretical advantage for the modulation of postmenopausal
cardiovascular target organ complications.
Additionally, drospirenone/estradiol therapy represents an attractive alternative to other forms of HT. (J Reprod Med 2007;52:165-168)
Keywords:  drospirenone, estradiol, hormone replacement therapy, postmenopause
  Acrobat Reader 7.0 is recommended to properly view and print the article.
Reader can be downloaded from